Clover Health Investments (7QD) Stock Statistics & Valuation Metrics
Total Valuation
Clover Health Investments has a market cap or net worth of EUR 2.22B. The enterprise value is EUR 2.86B.
- Market Cap
- EUR 2.22B
- Enterprise Value
- EUR 2.86B
Share Statistics
Clover Health Investments has 435,441,350 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 435,441,350
- Owned by Insiders
- 6.67%
- Owned by Institutions
- 22.54%
Financial Efficiency
Clover Health Investments’s return on equity (ROE) is -0.28 and return on invested capital (ROIC) is -25.75%.
- Return on Equity (ROE)
- -0.28
- Return on Assets (ROA)
- -0.16
- Return on Invested Capital (ROIC)
- -25.75%
- Return on Capital Employed (ROCE)
- -0.26
- Revenue Per Employee
- 2.66M
- Profits Per Employee
- -118.16K
- Employee Count
- 724
- Asset Turnover
- 3.56
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Clover Health Investments is 263.53. Clover Health Investments’s PEG ratio is 1.25.
- PE Ratio
- 263.53
- PS Ratio
- 0.87
- PB Ratio
- 6.09
- Price to FCF
- 17.99
- Price to Operating Cash Flow
- 17.60
- PEG Ratio
- 1.25
Income Statement
In the last 12 months, Clover Health Investments had revenue of 1.92B and earned -85.55M in profits. Earnings per share was -0.17.
- Revenue
- 1.92B
- Gross Profit
- 355.88M
- Operating Income
- -85.53M
- Pretax Income
- -85.55M
- Net Income
- -85.55M
- EBITDA
- -83.86M
- Earnings Per Share (EPS)
- -0.17
Cash Flow
In the last 12 months, operating cash flow was 135.31M and capital expenditures -3.03M, giving a free cash flow of 132.28M billion.
- Operating Cash Flow
- 135.31M
- Free Cash Flow
- 132.28M
- Free Cash Flow per Share
- 0.25
Dividends & Yields
Clover Health Investments pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 5.55%
- Earnings Yield
- 0.52%
Stock Price Statistics
- Beta
- 0.48
- 52-Week Price Change
- 21.13%
- 50-Day Moving Average
- 3.89
- 200-Day Moving Average
- 3.05
- Relative Strength Index (RSI)
- 45.32
- Average Volume (3m)
- 344
Important Dates
Clover Health Investments upcoming earnings date is Mar 04, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 04, 2026
- Next Earnings Date
- Mar 04, 2027
- Ex-Dividend Date
- ―
Financial Position
Clover Health Investments as a current ratio of 1.47, with Debt / Equity ratio of 0.00%
- Current Ratio
- 1.47
- Quick Ratio
- 1.47
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.93
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Clover Health Investments has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Clover Health Investments EV to EBITDA ratio is 145.21, with an EV/FCF ratio of 15.98.
- EV to Sales
- 0.77
- EV to EBITDA
- 145.21
- EV to Free Cash Flow
- 15.98
- EV to Operating Cash Flow
- 15.62
Balance Sheet
Clover Health Investments has EUR 272.58M in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of EUR 272.58M billion.
- Cash & Marketable Securities
- EUR 272.58M
- Total Debt
- EUR 0.00
- Net Cash
- EUR 272.58M
- Net Cash Per Share
- EUR 0.63
- Tangible Book Value Per Share
- EUR 0.73
Margins
Gross margin is 18.86%, with operating margin of 0.45%, and net profit margin of 0.45%.
- Gross Margin
- 18.86%
- Operating Margin
- 0.45%
- Pretax Margin
- 0.45%
- Net Profit Margin
- 0.45%
- EBITDA Margin
- 0.53%
- EBIT Margin
- 0.45%
Analyst Forecast
The average price target for Clover Health Investments is EUR 5.11, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- EUR 5.11
- Price Target Upside
- 33.40% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 4
- Revenue Growth Forecast
- 46.70%
- EPS Growth Forecast
- ―
Scores
- Smart Score
- 9
- AI Score
- ―
